|
Friday, 10 May 2013 23:04 |
Disease-in-a-dish models show promise for treating ataxia telangiectasiaLed by Dr. Peiyee Lee and Dr. Richard Gatti, researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have used induced pluripotent stem (iPS) cells to advance disease-in-a-dish modeling of a rare genetic disorder, ataxia telangiectasia (A-T). |
|
Read more...
|
|
Saturday, 06 April 2013 16:30 |
|
Cells from patients' blood could be developed as treatments for heart and circulatory diseases.
Scientists have shed light on a common bleeding disorder by growing and analysing stem cells from patients’ blood to discover the cause of the disease in individual patients. |
|
Read more...
|
|
Sunday, 09 December 2012 21:54 |
|
(Philadelphia, PA) – Despite treatment with imatinib, a successful drug that targets chronic myeloid leukemia (CML), a deadly type of cancer, some patients may continue to be at risk for relapse because a tiny pool of stem cells is resistant to treatment and may even accumulate additional genetic aberrations, eventually leading to disease progression and relapse. These leukemia stem cells are full of genetic errors, loaded with potentially lethal breaks in DNA, and are in a state of constant self-repair. |
|
Read more...
|
|
Monday, 19 November 2012 01:16 |
|
STANFORD, Calif. — Stanford University School of Medicine scientists have demonstrated, in a study conducted jointly with researchers at Yale University, that induced-pluripotent stem cells — the embryonic-stem-cell lookalikes whose discovery a few years ago won this year's Nobel Prize in medicine — are not as genetically unstable as was thought. |
|
Read more...
|
|
Saturday, 13 October 2012 20:40 |
|
WINSTON-SALEM, N.C. – Oct. 12, 2012 – Scientists at Wake Forest Baptist Medical Center have taken the first steps to create neural-like stem cells from muscle tissue in animals. Details of the work are published in two complementary studies published in the September online issues of the journals Experimental Cell Research and Stem Cell Research. |
|
Read more...
|
|
Sunday, 23 September 2012 03:24 |
|
September 21, 2012 – (BRONX, NY) – The promise of stem cells seems limitless. If they can be coaxed into rebuilding organs, repairing damaged spinal cords and restoring ravaged immune systems, these malleable cells would revolutionize medical treatment. But stem cell research is still in its infancy, as scientists seek to better understand the role of these cells in normal human development and disease. |
|
Read more...
|
|
Sunday, 08 July 2012 22:53 |
|
HOUSTON -- (July 8, 2012) -- A transcription factor called Lyl-1 is necessary for production of the earliest cells that can become T-cells, critical cells born in the thymus that coordinate the immune response to cancer or infections, said a consortium of researchers led by those from Baylor College of Medicine in a report in the journal Nature Immunology. |
|
Read more...
|
|
Sunday, 13 May 2012 05:58 |
|
New research findings show that embryonic stem cells unable to fully compact the DNA inside them cannot complete their primary task: differentiation into specific cell types that give rise to the various types of tissues and structures in the body. |
|
Read more...
|
|
Sunday, 08 April 2012 20:15 |
|
Post-doctoral researcher David Fluri and Professor Peter Zandstra at the University of Toronto's Institute of Biomaterials and Biomedical Engineering (IBBME) have developed a unique new technique for growing stem cells that may make possible cost-effective, large-scale stem cell manufacturing and research. |
|
Read more...
|
|
Saturday, 17 March 2012 21:10 |
A research team has identified epigenetic signatures, markers on DNA that control transient changes in gene expression, within reprogrammed skin cells. These signatures can predict the expression of a wound healing protein in reprogrammed skin cells or induced pluripotent stem cells (iPSCs), cells that take on embryonic stem cell properties. Understanding how the expression of the protein is controlled brings us one step closer to developing personalized tissue regeneration strategies using stem cells from a patient, instead of using human embryonic stem cells. The study was published in the Journal of Cell Science.
|
|
Read more...
|
|
|
Sunday, 05 May 2013 00:32 |
|
Gene thought to make heart tissues turns out to make blood and muscles as well New research out of the Lillehei Heart Institute at the University of Minnesota shows that by turning on just a single gene, Mesp1, different cell types including the heart, blood and muscle can be created from stem cells. The study was published in the journal Cell Stem Cell. |
|
Read more...
|
|
Saturday, 02 February 2013 01:03 |
|
The finding will, in the future, allow obtaining cells in a lab for therapeutic purposes. Researchers from the group on stem cells and cancer at IMIM (Hospital del Mar Medical Research Institute) have deciphered one of the gene regulation circuits which would make it possible to generate hematopoietic blood cells, i.e. blood tissue stem cells. This finding is essential to generate these cells in a laboratory in the future, a therapy that could benefit patients with leukaemia or other diseases who need a transplant and who, in many cases, do not have a compatible donor. |
|
Read more...
|
|
Saturday, 24 November 2012 13:55 |
|
THREE-DIMENSIONAL
Scientists from The Danish Stem Cell Center (DanStem) at the University of Copenhagen are contributing important knowledge about how stem cells develop best into insulin-producing cells. In the long term this new knowledge can improve diabetes treatment with cell therapy. The results have just been published in the scientific journal Cell Reports. |
|
Read more...
|
|
Friday, 26 October 2012 22:19 |
|
Baltimore, MD— The ability of embryonic stem cells to differentiate into different types of cells with different functions is regulated and maintained by a complex series of chemical interactions, which are not well understood. Learning more about this process could prove useful for stem cell-based therapies down the road. New research from a team led by Carnegie’s Yixian Zheng zeroes in on the process by which stem cells maintain their proper undifferentiated state. Their results are published in CellOctober 26.
|
|
Read more...
|
|
Sunday, 23 September 2012 03:40 |
|
ScienceDaily (Sep. 18, 2012) — Salk scientists have identified a unique molecular signature in induced pluripotent stem cells (iPSCs), "reprogrammed" cells that show great promise in regenerative medicine thanks to their ability to generate a range of body tissues. |
|
Read more...
|
|
Monday, 03 September 2012 14:17 |
|
UCLA researchers have discovered a type of cell that is the "missing link" between bone marrow stem cells and all the cells of the human immune system, a finding that will lead to a greater understanding of how a healthy immune system is produced and how disease can lead to poor immune function. The studies were done using human bone marrow, which contains all the stem cells that produce blood during postnatal life. |
|
Read more...
|
|
Monday, 11 June 2012 15:54 |
|
Tampa, Fla. (June 11 , 2012) –Researchers in Japan have found that hepatocytes, cells comprising the main tissue of the liver and involved in protein synthesis and storage, can assist in tissue engineering and create a "new liver system" in mouse models when donor mouse liver hepatocytes are isolated and propagated for transplantation. Their study is published in a recent issue of Cell Transplantation (21:2/3), now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/. |
|
Read more...
|
|
Thursday, 12 April 2012 14:08 |
|
In a recently published article, two myeloma experts discussed the role of autologous stem cell transplantation as an initial line of therapy in myeloma patients. The debate centered on the limited evidence supporting stem cell transplants in the context of newer, alternative treatment options. |
|
Read more...
|
|
Sunday, 25 March 2012 06:23 |
Switch may release fuel and materials for rapid growth and formation of layers that later become organs. Shortly after a mouse embryo starts to form, some of its stem cells undergo a dramatic metabolic shift to enter the next stage of development, Seattle researchers report today. These stem cells start using and producing energy like cancer cells. |
|
Read more...
|
|
Saturday, 17 March 2012 21:06 |
|
Huntington's disease, the debilitating congenital neurological disorder that progressively robs patients of muscle coordination and cognitive ability, is a condition without effective treatment, a slow death sentence. |
|
Read more...
|
|